MicroVision,
Inc.
|
||
|
||
Balance
Sheet
|
||
(In
thousands)
|
||
(Unaudited)
|
||
|
June
30,
|
December
31,
|
|
2021
|
2020
|
|
|
|
Assets
|
|
|
Current
Assets
|
|
|
Cash
and cash equivalents
|
$135,288
|
$16,862
|
Inventory
|
151
|
-
|
Other
current assets
|
885
|
698
|
Total
current assets
|
136,324
|
17,560
|
|
|
|
Property and
equipment, net
|
2,742
|
1,883
|
Operating lease
right-of-use asset
|
753
|
946
|
Restricted
cash
|
435
|
435
|
Intangible assets,
net
|
139
|
164
|
Other
assets
|
24
|
18
|
Total
assets
|
$140,417
|
$21,006
|
|
|
|
|
|
|
Liabilities
and Shareholders' Equity
|
|
|
Current
Liabilities
|
|
|
Accounts
payable
|
$1,540
|
$630
|
Accrued
liabilities
|
641
|
495
|
Contract
liabilities
|
6,540
|
7,765
|
Current
portion of long-term debt
|
968
|
431
|
Current
portion of operating lease liability
|
686
|
676
|
Current
portion of finance lease obligations
|
24
|
31
|
Total
current liabilities
|
10,399
|
10,028
|
|
|
|
Long term debt, net
of current portion
|
621
|
1,151
|
Operating lease
liability, net of current portion
|
467
|
774
|
Finance lease
obligations, net of current portion
|
33
|
44
|
Total
liabilities
|
11,520
|
11,997
|
|
|
|
Commitments and
contingencies
|
|
|
|
|
|
Shareholders'
Equity
|
|
|
Common
stock at par value
|
164
|
153
|
Additional
paid-in capital
|
736,159
|
601,224
|
Subscriptions
receivable
|
-
|
(6,135)
|
Accumulated
deficit
|
(607,426)
|
(586,233)
|
Total
shareholders' equity
|
128,897
|
9,009
|
Total liabilities
and shareholders' equity
|
$140,417
|
$21,006
|
MicroVision, Inc.
Statement of Operations
(In thousands, except earnings per share
data)
(Unaudited)
|
||||
|
||||
|
Three months
ended June 30,
|
Six
months ended June 30,
|
||
|
2021
|
2020
|
2021
|
2020
|
|
|
|
|
|
Product
revenue
|
$-
|
$-
|
$-
|
$1,247
|
License and royalty
revenue
|
746
|
572
|
1,225
|
784
|
Contract
revenue
|
-
|
15
|
-
|
25
|
Total
revenue
|
746
|
587
|
1,225
|
2,056
|
|
|
|
|
|
Cost of product
revenue
|
(31)
|
(1)
|
(36)
|
1,394
|
Cost of contract
revenue
|
-
|
-
|
-
|
4
|
Total cost of
revenue
|
(31)
|
(1)
|
(36)
|
1,398
|
|
|
|
|
|
Gross
margin
|
777
|
588
|
1,261
|
658
|
|
|
|
|
|
Research and
development expense
|
7,376
|
1,607
|
11,838
|
5,290
|
Sales, marketing,
general and administrative expense
|
8,355
|
1,280
|
10,602
|
3,051
|
Gain on disposal of
fixed assets
|
-
|
-
|
-
|
(450)
|
Total operating
expenses
|
15,731
|
2,887
|
22,440
|
7,891
|
|
|
|
|
|
Loss from
operations
|
(14,954)
|
(2,299)
|
(21,179)
|
(7,233)
|
|
|
|
|
|
Other expense,
net
|
(8)
|
(5)
|
(14)
|
(5)
|
|
|
|
|
|
Net
loss
|
$(14,962)
|
$(2,304)
|
$(21,193)
|
$(7,238)
|
|
|
|
|
|
Net loss per share
- basic and diluted
|
$(0.09)
|
$(0.02)
|
$(0.13)
|
$(0.05)
|
|
|
|
|
|
Weighted-average
shares outstanding - basic and diluted
|
158,818
|
140,107
|
157,136
|
133,661
|